Drug-eluting stents for the prevention of restenosis: in quest for the Holy Grail

Catheter Cardiovasc Interv. 2002 Mar;55(3):409-17. doi: 10.1002/ccd.10161.
No abstract available

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Clinical Trials as Topic
  • Coated Materials, Biocompatible*
  • Coronary Restenosis / etiology
  • Coronary Restenosis / prevention & control*
  • Dactinomycin / administration & dosage
  • Depression, Chemical
  • Humans
  • Infusion Pumps, Implantable*
  • Muscle, Smooth, Vascular / cytology
  • Paclitaxel / administration & dosage
  • Paclitaxel / pharmacology
  • Sirolimus / administration & dosage
  • Sirolimus / pharmacology
  • Stents* / adverse effects

Substances

  • Coated Materials, Biocompatible
  • Dactinomycin
  • Paclitaxel
  • Sirolimus